featured
Better Outcomes With Addition of Ezetimibe to Simvastatin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT
Circulation 2015 Sep 01;[EPub Ahead of Print], EA Bohula, RP Giugliano, CP Cannon, J Zhou, SA Murphy, JA White, AM Tershakovec, MA Blazing, E BraunwaldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.